Compare BSX & MMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | MMM |
|---|---|---|
| Founded | 1979 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 79.1B |
| IPO Year | 2010 | 2005 |
| Metric | BSX | MMM |
|---|---|---|
| Price | $64.58 | $145.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 22 | 8 |
| Target Price | $96.95 | ★ $170.88 |
| AVG Volume (30 Days) | ★ 16.4M | 2.8M |
| Earning Date | 04-22-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.14% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | ★ 1.94 | 1.23 |
| Revenue | $9,076,000,000.00 | ★ $24,948,000,000.00 |
| Revenue This Year | $11.85 | $1.78 |
| Revenue Next Year | $10.16 | $3.17 |
| P/E Ratio | ★ $33.25 | $118.58 |
| Revenue Growth | ★ 12.49 | 1.52 |
| 52 Week Low | $59.52 | $134.85 |
| 52 Week High | $109.50 | $177.41 |
| Indicator | BSX | MMM |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 41.54 |
| Support Level | $60.59 | $141.78 |
| Resistance Level | $76.77 | $160.38 |
| Average True Range (ATR) | 1.75 | 3.80 |
| MACD | 0.43 | 0.40 |
| Stochastic Oscillator | 82.22 | 20.28 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.